GGrantIndex
← Leaderboards

Robert B Abramovitch

Cornell University

$8,804,658
Attributed
$11,247,308
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,247,308 · 10

By mechanism

R01$9,589,854 · 4
R21$1,215,194 · 3
R03$312,085 · 2
F32$130,175 · 1

Top collaborators

Most similar at Cornell University

Same institution · by research overlap

Others in their field

Top investigators on “Mycobacterium Tuberculosis

Research focus

Mycobacterium TuberculosisAmericanResistant StrainTuberculosisPharmaceutical PreparationsCessation Of LifeMutantDrug ResistanceIn VitroNational Institute Of Allergy And Infectious DiseaseMissionGlobal HealthIn VivoAntibioticsDisease TransmissionPhenotypeGrowthCellsTuberculosis TreatmentInfectionPredispositionMacrophageResistanceImmune System

Grant awards (27)

New potent orally bioavailable nitro-containing compounds to treat mycobacterial infections$2,248,740
R01 · FY2025 · AI · contact PI
Chemical biology studies of MmpL3 inhibition and resistance in mycobacteria$729,894
R01 · FY2025 · AI · contact PI
Defining the antibacterial activities of ozonides$77,931
R03 · FY2025 · AI · contact PI
Chemical biology studies of MmpL3 inhibition and resistance in mycobacteria$747,825
R01 · FY2024 · AI · contact PI
Chemical genetics of M. tuberculosis DosRST signaling and persistence$359,866
R01 · FY2024 · AI · contact PI
Defining the antibacterial activities of ozonides$85,286
R03 · FY2024 · AI · contact PI
Chemical biology studies of MmpL3 inhibition and resistance in mycobacteria$758,959
R01 · FY2023 · AI · contact PI
Chemical genetics of M. tuberculosis DosRST signaling and persistence$655,967
R01 · FY2023 · AI · contact PI
Chemical genetics of M. tuberculosis DosRST signaling and persistence$730,444
R01 · FY2022 · AI · contact PI
Chemical genetics of M. tuberculosis DosRST signaling and persistence$725,918
R01 · FY2021 · AI · contact PI
Development of new M. tuberculosis MmpL3 inhibitors$230,979
R21 · FY2021 · AI · contact PI
Characterizing new M. tuberculosis inhibitors discovered in the Molecular Libraries Small Molecule Repository$74,359
R03 · FY2021 · AI · contact PI
Chemical genetics of M. tuberculosis DosRST signaling and persistence$717,958
R01 · FY2020 · AI · contact PI
Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation$379,939
R01 · FY2020 · AI · contact PI
Development of new M. tuberculosis MmpL3 inhibitors$191,999
R21 · FY2020 · AI · contact PI
Characterizing new M. tuberculosis inhibitors discovered in the Molecular Libraries Small Molecule Repository$74,509
R03 · FY2020 · AI · contact PI
Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation$380,231
R01 · FY2019 · AI · contact PI
Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation$380,510
R01 · FY2018 · AI · contact PI
Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation$380,779
R01 · FY2017 · AI · contact PI
Non-competitive proteasome inhibitors to treat chronic, drug-resistant tuberculosis$219,058
R21 · FY2017 · AI · contact PI
Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation$392,824
R01 · FY2016 · AI · contact PI
Non-competitive proteasome inhibitors to treat chronic, drug-resistant tuberculosis$180,825
R21 · FY2016 · AI · contact PI
Screening for inhibitors of M. tuberculosis persistence-related lipid metabolism$202,234
R21 · FY2014 · AI · contact PI
Screening for inhibitors of M. tuberculosis persistence-related lipid metabolism$190,099
R21 · FY2013 · AI · contact PI
Genetics of Mycobacterium tuberculosis adaptation to the macrophage phagosome$28,375
F32 · FY2011 · AI · contact PI
Genetics of Mycobacterium tuberculosis adaptation to the macrophage phagosome$52,154
F32 · FY2010 · AI · contact PI
Genetics of Mycobacterium tuberculosis adaptation to the macrophage phagosome$49,646
F32 · FY2009 · AI · contact PI